thesis-toulmin
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q35856790-9C8D1FE0-D4CD-4280-AEAD-F0851484D40A
Q35856790-9C8D1FE0-D4CD-4280-AEAD-F0851484D40A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35856790-9C8D1FE0-D4CD-4280-AEAD-F0851484D40A
The Bone Marrow-Mediated Protection of Myeloproliferative Neoplastic Cells to Vorinostat and Ruxolitinib Relies on the Activation of JNK and PI3K Signalling Pathways.
P2860
Q35856790-9C8D1FE0-D4CD-4280-AEAD-F0851484D40A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35856790-9C8D1FE0-D4CD-4280-AEAD-F0851484D40A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e7386a0f28e3aa28f1e5fcb8afba3ce8f18936d0
P2860
A phase 2 study of ruxolitinib, an oral JAK1 and JAK2 Inhibitor, in patients with advanced polycythemia vera who are refractory or intolerant to hydroxyurea.